SEARCH BY NAME

BROWSE

Browse Australian delisted companies

0-9A BC DE F GH IJ KL MN OP QR ST UV WX YZ

Browse terminated Australian managed funds

0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

DIA-B TECH LIMITED (DIA)

Former Name ASX

SHARE PRICES

Former (or subsequent) names

 FROMTO
PALLANE MEDICAL LIMITED20/11/2009
DIA-B TECH LIMITED20/11/2009

Shareholder links

 

REGISTRY:
Security Transfer Australia Pty Ltd, 770 Canning Highway Applecross WA 6153
Tel : +61 3 9628 2200
Fax : +61 8 9315 2233
RegistryWebsite RegistryEmail

Company details

Address: Suites 1133-1139 No 1 Queens Road Melbourne VIC 3004
Tel:  +61 3 9863 9557 Fax: +61 3 9863 9556

Date first listed: 24/01/2005
Company Secretary: Mr Santino Di-Giacomo
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Discovery and development of pharmaceuticals, diagnostics and treatments for diabetes and diabetes-related diseases
name changed to Pallane Medical Limited20/11/2009
releases Annual Financial Report30/10/2009
following the recent default of the Pallane Medical underwriting by Winteray Capital, that the Company has undertaken a review of all options available - following extensive negotiations, the convertible note holder in DIA, Trafalgar Capital Specialized Investment Fund, will take control of the Company through an agreement to convert the majority of the current convertible debt holdings into equity, subject to shareholder approval - the Board believes this is in the best interest of all creditors and shareholders - the Chairman, Dr Michael Wooldridge, non-executive Director Mr Neil Hewitt and CEO/Company Secretary Mr Ken Smith have stood aside and facilitated the appointment of the new Directors and management05/10/2009
advises that it has received a notice of termination in relation to the share sale agreement for the acquisition of Pallane Medical Pty Ltd (Pallane). The Company's proposed acquisition of Pallane, as announced to the market on 12 February 2009, will no longer be completed on the terms of that agreement13/08/2009
advises that Winteray Capital Pty Ltd, the underwriter under the Company's capital raising to fund the acquisition of Pallane Medical Pty Ltd (Offer), has not, to date, satisfied its obligation under the terms of the underwriting agreement to cause applications subscribing for the ordinary shares comprising the shortfall under the Offer to be lodged with the Company by Monday, 10 August 2009. The Company is seeking advice on this matter and will inform the market immediately of any further developments11/08/2009
the Company advises that the offer period for its capital raising to fund the acquisition of Pallane Medical Pty Ltd closed Friday 31 July 2009 - there was a substantial shortfall in applications for shares in the Offer - the Offer is underwritten by Winteray Capital Pty Ltd (Underwriter) to the amount of $12.5 million - immediately following the close of the Offer, the Company served on the Underwriter a shortfall notice for the Underwriter to take up the Shortfall - in accordance with the terms of the underwriting agreement with the Underwriter, the Company expects applications to be lodged to subscribe for the ordinary shares comprising the Shortfall by no later than Monday, 10 August 200903/08/2009
company advises that it has extended the offer period for its capital raising to fund the acquisition of Pallane Medical Pty Ltd 2009 until Friday, 31 July 200928/07/2009
the process to consolidate the shares and options of the Company on a twenty (20) for one (1) basis is now complete in accordance with section 254H(1) of the Corporations Act. The consolidation was approved by shareholders at the Company's general meeting held on the 29 th June 200908/07/2009
the securities of Dia-B Tech Limited (the "Company") will be suspended from quotation immediately following security holder approval of the Company's acquisition of Pallane Medical Pty Limited and resultant change of activities29/06/2009
securities reinstated to quotation13/02/2009
the securities of Dia-B Tech Ltd (the "Company") will be suspended from quotation immediately, following the Company's announcement concerning the proposed acquisition of Pallane Medical Pty Ltd (the "Acquisition"). Unless ASX decides otherwise, the securities of the Company will be reinstated to official quotation prior to the commencement of trading on Friday, 13 February 200912/02/2009

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

     

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Ravindran GovindanChairman05/10/2009
    Joanna BroedersDirector05/10/2009
    Sam Di-GiacomoDirector05/10/2009
    Peter StaffordDirector05/10/2009

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION

    Date of first appointment, title may have changed.